1. Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
   Stella Sun et al, 2012, Journal of Neuro-Oncology CrossRef
2. Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma
   Jian Shen et al, 2012, PLoS ONE CrossRef
3. Mathematical Prognostic Biomarker Models for Treatment Response and survival in Epithelial Ovarian Cancer
   Jason B. Nikas et al, 2011, Cancer Informatics CrossRef
4. Expression and Prognostic Significance of APE1/Ref-1 and NPM1 Proteins in High-Grade Ovarian Serous Cancer
   Ambrogio P. Londero et al, 2014, American Journal of Clinical Pathology CrossRef
5. Multifunctional molecule ERp57: From cancer to neurodegenerative diseases
   Aubryanna Hettinghouse et al, 2018, Pharmacology & Therapeutics CrossRef
6. MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3
   SHUZHEN ZHAO et al, 2015, Molecular Medicine Reports CrossRef
7. The protein ERp57 contributes to EGF receptor signaling and internalization in MDA-MB-468 breast cancer cells
   Elisa Gaucci et al, 2013, Journal of Cellular Biochemistry CrossRef
8. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma
   Ryota Kondo et al, 2019, International Journal of Oncology CrossRef
9. Comparative proteome analysis of monolayer and spheroid culture of canine osteosarcoma cells
   Christiane Gebhard et al, 2018, Journal of Proteomics CrossRef
10. Single-cell Transcriptome Analyses Reveal Molecular Signals to Intrinsic and Acquired Paclitaxel Resistance in Esophageal Squamous Cancer Cells
    Hongjin Wu et al, 2018, Cancer Letters CrossRef
11. ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel
    Shou Li et al, 2018, International Journal of Oncology CrossRef
12. Tumor necrosis factor‐α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D3‐MARRS to the nucleus
    Brian J. Grindel et al, 2011, Journal of Cellular Biochemistry CrossRef
13. A Transcriptome-proteome Integrated Network Identifies Endoplasmic Reticulum thiol oxidoreductase (ERp57) as a Hub that Mediates Bone Metastasis
    Naiara Santana-Codina et al, 2013, Molecular & Cellular Proteomics CrossRef
14. In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
    Tobias Ocklenburg et al, 2021, Scientific Reports CrossRef
15. Comparative 2D-DIGE proteomic analysis of ovarian carcinoma cells: Toward a reorientation of biosynthesis pathways associated with acquired platinum resistance
    Hubert Lincet et al, 2012, Journal of Proteomics CrossRef
16. Upregulation of phosphorylated cofilin 1 correlates with taxol resistance in human ovarian cancer in vitro and in vivo
    MIN LI et al, 2013, Oncology Reports CrossRef
17. ERp57/GRP58: A protein with multiple functions
    Carlo Turano et al, 2011, Cellular and Molecular Biology Letters CrossRef
18. ERp57/PDIA3 binds specific DNA fragments in a melanoma cell line
    Cristina Aureli et al, 2013, Gene CrossRef